These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34336902)

  • 1. Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis.
    Zhang Y; Huang C; Nie Y; Liu Q; Xiao N; Liu L; Zhu X
    Front Med (Lausanne); 2021; 8():698502. PubMed ID: 34336902
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessing the Prognostic Performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin Scores in Patients with Decompensated Cirrhosis: A Large Asian Cohort from Gastroenterology Department.
    Wan SZ; Nie Y; Zhang Y; Liu C; Zhu X
    Dis Markers; 2020; 2020():5193028. PubMed ID: 32148566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scoring systems for prediction of mortality in decompensated liver cirrhosis: A meta-analysis of test accuracy.
    Wu SL; Zheng YX; Tian ZW; Chen MS; Tan HZ
    World J Clin Cases; 2018 Dec; 6(15):995-1006. PubMed ID: 30568954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis.
    Wang J; Zhang Z; Yan X; Li M; Xia J; Liu Y; Chen Y; Jia B; Zhu L; Zhu C; Huang R; Wu C
    Dig Liver Dis; 2019 Aug; 51(8):1172-1178. PubMed ID: 30765220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of insulin-like growth factor 1-Child-Turcotte-Pugh score for mortality in patients with decompensated cirrhosis.
    Yao Y; Yang D; Huang Y; Dong M
    Clin Chim Acta; 2020 Jun; 505():141-147. PubMed ID: 32119835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.
    Chen PC; Chen BH; Huang CH; Jeng WJ; Hsieh YC; Teng W; Chen YC; Ho YP; Sheen IS; Lin CY
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1256-1263. PubMed ID: 31498284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of model for end-stage liver disease and Child-Turcotte-Pugh scores over time in evaluating the prognosis of patients with decompensated cirrhosis: experience in the Chinese mainland.
    Bie CQ; Yang DH; Tang SH; Huang W
    Hepatol Res; 2009 Aug; 39(8):779-85. PubMed ID: 19473429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of risk scoring systems for cirrhotic patients with variceal bleeding.
    Tantai XX; Liu N; Yang LB; Wei ZC; Xiao CL; Song YH; Wang JH
    World J Gastroenterol; 2019 Dec; 25(45):6668-6680. PubMed ID: 31832005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Child-Turcotte-Pugh versus model for end stage liver disease score for predicting survival in hospitalized patients with decompensated cirrhosis.
    Chaurasia RK; Pradhan B; Chaudhary S; Jha SM
    J Nepal Health Res Counc; 2013 Jan; 11(23):9-16. PubMed ID: 23787518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the prognostic value of mortality Child Pugh Score and forecasting models of chronic liver disease in patients with decompensated cirrhosis of the Hospital Nacional Cayetano Heredia, Lima-Peru].
    Valenzuela Granados V; Salazar-Quiñones M; Cheng-Zárate L; Malpica-Castillo A; Huerta Mercado J; Ticse R
    Rev Gastroenterol Peru; 2015; 35(4):307-12. PubMed ID: 26802883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ability of the new ALBI scoring in predicting mortality, complications and prognostic comparison among cirrhotics.
    Naqvi IH; Talib A; Mahmood K; Abidi R; Rizvi SNZ
    Prz Gastroenterol; 2019; 14(4):250-257. PubMed ID: 31988671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALBI and PALBI Grades Are Associated with the Outcome of Patients with Stable Decompensated Cirrhosis.
    Oikonomou T; Goulis L; Doumtsis P; Tzoumari T; Akriviadis E; Cholongitas E
    Ann Hepatol; 2019; 18(1):126-136. PubMed ID: 31113581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.
    Chawla YK; Kashinath RC; Duseja A; Dhiman RK
    J Clin Exp Hepatol; 2011 Dec; 1(3):161-8. PubMed ID: 25755381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
    Cheng XP; Zhao J; Chen Y; Meng FK; Xu B; Yu HW; Meng QH; Liu YM; Zhang SB; Meng S; Zhang JY; Zhang JY; Duan ZP; Zheng SJ
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):444-8. PubMed ID: 26649802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
    Tornai T; Vitalis Z; Sipeki N; Dinya T; Tornai D; Antal-Szalmas P; Karanyi Z; Tornai I; Papp M
    Liver Int; 2016 Nov; 36(11):1628-1638. PubMed ID: 27031405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of creatinine-modified Child Pugh score for predicting short-term prognosis of patients with decompensated cirrhosis of liver as compare to original child Pugh score.
    Samiullah S; Qasim R; Khalid S; Hussain BG; Mukhtair J; Akbar Y
    J Ayub Med Coll Abbottabad; 2009; 21(2):64-7. PubMed ID: 20524472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of albumin-bilirubin grade for evaluation of long-term prognosis for hepatitis B-related cirrhosis.
    Chen RC; Cai YJ; Wu JM; Wang XD; Song M; Wang YQ; Zheng MH; Chen YP; Lin Z; Shi KQ
    J Viral Hepat; 2017 Mar; 24(3):238-245. PubMed ID: 27862671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lactate level predicts 6-months mortality in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective study.
    Nie Y; Liu LX; Chen T; Zhang Y; Zhu X
    Epidemiol Infect; 2021 Jan; 149():e26. PubMed ID: 33397544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.
    Grønbaek H; Sandahl TD; Mortensen C; Vilstrup H; Møller HJ; Møller S
    Aliment Pharmacol Ther; 2012 Jul; 36(2):173-80. PubMed ID: 22591184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin-Bilirubin Score Predicts Short-Term Mortality in Patients with Hepatitis B Virus-Related Decompensated Cirrhosis.
    Qi XT
    Clin Lab; 2018 May; 64(5):777-783. PubMed ID: 29739046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.